Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118834952 | 11883495 | 2 | F | 20160825 | 20151231 | 20160830 | EXP | PHHY2014BR146269 | NOVARTIS | 0.00 | M | Y | 90.00000 | KG | 20160830 | MD | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118834952 | 11883495 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO | 21008 | 20 | MG | SUSPENSION | /month | ||||||
118834952 | 11883495 | 2 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
118834952 | 11883495 | 3 | C | GLIFAGE XR | METFORMIN HYDROCHLORIDE | 1 | Oral | 1 DF, QHS | 0 | 1 | DF | EXTENDED RELEASE TABLET | |||||||
118834952 | 11883495 | 4 | C | CAPTOPRIL. | CAPTOPRIL | 1 | Oral | 3 DF, QD | Y | 0 | 3 | DF | TABLET | QD | |||||
118834952 | 11883495 | 5 | C | CAPTOPRIL. | CAPTOPRIL | 1 | Unknown | 30 MG, QHS | Y | 0 | 30 | MG | TABLET | ||||||
118834952 | 11883495 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 1 DF, QHS | Y | 0 | 1 | DF | TABLET | ||||||
118834952 | 11883495 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
118834952 | 11883495 | 8 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
118834952 | 11883495 | 9 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | TABLET | |||||||||||
118834952 | 11883495 | 10 | C | TOFRANIL | IMIPRAMINE HYDROCHLORIDE | 1 | Oral | 35 MG (1 TABLET OF 25 MG AND 1 TABLET OF 10 MG), QHS | 0 | 35 | MG | TABLET | |||||||
118834952 | 11883495 | 11 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 2 DF, BID | 0 | 2 | DF | BID | |||||||
118834952 | 11883495 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 2 DF, QD | 0 | 2 | DF | QD | |||||||
118834952 | 11883495 | 13 | C | DEPOSTERON | 2 | Intramuscular | 1 DF, QD | 0 | 1 | DF | INJECTION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118834952 | 11883495 | 1 | Acromegaly |
118834952 | 11883495 | 2 | Thyroid disorder |
118834952 | 11883495 | 3 | Diabetes mellitus |
118834952 | 11883495 | 4 | Blood pressure increased |
118834952 | 11883495 | 6 | Blood cholesterol increased |
118834952 | 11883495 | 7 | Acromegaly |
118834952 | 11883495 | 8 | Anxiety |
118834952 | 11883495 | 9 | Depression |
118834952 | 11883495 | 10 | Depression |
118834952 | 11883495 | 11 | Blood pressure increased |
118834952 | 11883495 | 12 | Product used for unknown indication |
118834952 | 11883495 | 13 | Blood testosterone abnormal |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118834952 | 11883495 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118834952 | 11883495 | Blood glucose decreased | |
118834952 | 11883495 | Cholelithiasis | |
118834952 | 11883495 | Depression | |
118834952 | 11883495 | Emotional disorder | |
118834952 | 11883495 | Hormone level abnormal | |
118834952 | 11883495 | Injection site pain | |
118834952 | 11883495 | Memory impairment | |
118834952 | 11883495 | Pneumonia | |
118834952 | 11883495 | Sexual dysfunction | |
118834952 | 11883495 | Sluggishness | |
118834952 | 11883495 | Somnolence | |
118834952 | 11883495 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118834952 | 11883495 | 1 | 2011 | 0 |